Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

View source ↗

Summary

A completed clinical trial evaluating PK/PD of ganciclovir in premature infants treated for CMV infection; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cytomegalovirus Infections | Status: COMPLETED | Results posted: 2020-05-19